Ignite Creation Date:
2025-12-24 @ 10:33 PM
Ignite Modification Date:
2025-12-29 @ 7:19 AM
Study NCT ID:
NCT00734435
Status:
TERMINATED
Last Update Posted:
2012-11-29
First Post:
2008-08-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects
Sponsor:
Orexigen Therapeutics, Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2008-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-12
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-12
First Submit QC Date:
None
Study First Post Date:
2008-08-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-11-29
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2012-11-27
Last Update Post Date:
2012-11-29
Last Update Post Date Type:
ESTIMATED